MedicarePartD.guide

A non-government resource built from CMS public data

GLP-1 drugs on every 2026 Puerto Rico Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 3 stand-alone Part D plans in Puerto Rico cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
GLP-1 drugs by 2026 Puerto Rico Part D plan
DrugHealthSpring Extra Rx$50.00/moS5617-385HealthSpring Assurance Rx$65.70/moS5617-348AARP Medicare Rx Preferred from UHC$145.10/moS5820-037
Ozempicsemaglutide injectionTier 3PA17%QL 3/28dTier 3PA22%QL 3/28dTier 3PA25%QL 3/28d
Mounjarotirzepatide injectionTier 3PA17%QL 2/28dTier 3PA22%QL 2/28dTier 3PA25%QL 2/28d
Trulicitydulaglutide injectionTier 3PA17%QL 2/28dTier 3PA22%QL 2/28dTier 3PA25%QL 2/28d
Ozempic tabletsoral semaglutide, formerly RybelsusTier 3PA17%QL 30/30dTier 3PA22%QL 30/30dTier 3PA25%QL 30/30d
Wegovysemaglutide, weightNot coveredNot coveredNot covered
Zepboundtirzepatide, weightNot coveredNot coveredNot covered
VictozaliraglutideNot coveredNot coveredNot covered
liraglutidegeneric VictozaNot coveredNot coveredNot covered
Saxendaliraglutide, weightNo 2026 Part D formulary lists this drug in the CMS files: it is too new, no longer sold, or excluded from Part D (as weight-loss-only drugs are).
ByettaexenatideNo 2026 Part D formulary lists this drug in the CMS files: it is too new, no longer sold, or excluded from Part D (as weight-loss-only drugs are).
Bydureon BCiseexenatide extended-releaseNo 2026 Part D formulary lists this drug in the CMS files: it is too new, no longer sold, or excluded from Part D (as weight-loss-only drugs are).
orforglipronoral GLP-1, approved 2026No 2026 Part D formulary lists this drug in the CMS files: it is too new, no longer sold, or excluded from Part D (as weight-loss-only drugs are).

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.